230 related articles for article (PubMed ID: 37133390)
1. The Efficiency of p27 Cleavage during
Rezende W; Ye X; Angelo LS; Carisey AF; Avadhanula V; Piedra PA
J Virol; 2023 May; 97(5):e0025423. PubMed ID: 37133390
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Blunck BN; Aideyan L; Ye X; Avadhanula V; Ferlic-Stark L; Zechiedrich L; Gilbert BE; Piedra PA
Vaccine; 2022 Jan; 40(3):536-543. PubMed ID: 34903371
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
Patel N; Massare MJ; Tian JH; Guebre-Xabier M; Lu H; Zhou H; Maynard E; Scott D; Ellingsworth L; Glenn G; Smith G
Vaccine; 2019 Sep; 37(41):6112-6124. PubMed ID: 31416644
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.
Kwon YM; Lee Y; Kim KH; Jung YJ; Li Z; Jeeva S; Lee S; Moore ML; Kang SM
Vaccine; 2019 Oct; 37(44):6656-6664. PubMed ID: 31542260
[TBL] [Abstract][Full Text] [Related]
5. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
[TBL] [Abstract][Full Text] [Related]
6. Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization.
Leemans A; Boeren M; Van der Gucht W; Pintelon I; Roose K; Schepens B; Saelens X; Bailey D; Martinet W; Caljon G; Maes L; Cos P; Delputte P
Viruses; 2018 Aug; 10(8):. PubMed ID: 30110893
[TBL] [Abstract][Full Text] [Related]
7. Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Hause AM; Henke DM; Avadhanula V; Shaw CA; Tapia LI; Piedra PA
PLoS One; 2017; 12(4):e0175792. PubMed ID: 28414749
[TBL] [Abstract][Full Text] [Related]
8. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
Zhang L; Durr E; Galli JD; Cosmi S; Cejas PJ; Luo B; Touch S; Parmet P; Fridman A; Espeseth AS; Bett AJ
Vaccine; 2018 Dec; 36(52):8119-8130. PubMed ID: 30340881
[TBL] [Abstract][Full Text] [Related]
11. Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain.
Lee J; Lee Y; Klenow L; Coyle EM; Tang J; Ravichandran S; Golding H; Khurana S
EMBO Mol Med; 2022 Jan; 14(1):e13847. PubMed ID: 34750984
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
13. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
Liang B; Matsuoka Y; Le Nouën C; Liu X; Herbert R; Swerczek J; Santos C; Paneru M; Collins PL; Buchholz UJ; Munir S
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115876
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response.
Borochova K; Niespodziana K; Focke-Tejkl M; Hofer G; Keller W; Valenta R
Sci Rep; 2021 Feb; 11(1):3551. PubMed ID: 33574352
[TBL] [Abstract][Full Text] [Related]
15. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
Liang B; Ngwuta JO; Surman S; Kabatova B; Liu X; Lingemann M; Liu X; Yang L; Herbert R; Swerczek J; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Collins PL; Munir S
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539444
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.
Blais N; Gagné M; Hamuro Y; Rheault P; Boyer M; Steff AM; Baudoux G; Dewar V; Demers J; Ruelle JL; Martin D
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404847
[TBL] [Abstract][Full Text] [Related]
18. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
[TBL] [Abstract][Full Text] [Related]
19. Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation.
Yunus AS; Jackson TP; Crisafi K; Burimski I; Kilgore NR; Zoumplis D; Allaway GP; Wild CT; Salzwedel K
Virology; 2010 Jan; 396(2):226-37. PubMed ID: 19922971
[TBL] [Abstract][Full Text] [Related]
20. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
